Advances in the Treatment of Hyperhidrosis

Tap into peer-to-peer dialogues covering different therapeutic areas in easy to digest videos, featuring managed care thought leaders.

Final Thoughts on Treating Hyperhidrosis
September 06, 2018 – 
Adelaide Hebert, MD; Andy Szczotka, PharmD; Dee Anna Glaser, MD; and Adam Friedman, MD, FAAD, wrap up the discussion with final thoughts on treating hyperhidrosis, including ways to increase patient access to treatments, educating clinicians and payers that hyperhidrosis is a medical condition, and encouraging patients to seek help to improve their quality of life.
Conquering Hyperhidrosis
August 30, 2018 – 
Dee Anna Glaser, MD; Adam Friedman, MD, FAAD; Adelaide Hebert, MD; and Andy Szczotka, PharmD, summarize different ways to conquer hyperhidrosis, including educating patients and school nurses that this is a treatable disease.
Insurance Coverage for Hyperhidrosis
August 30, 2018 – 
Dee Anna Glaser, MD; Adelaide Hebert, MD; Adam Friedman, MD, FAAD; and Andy Szczotka, PharmD, provide insight into helping patients understand their insurance coverage, nuances within their plans, and managing hyperhidrosis as a lifelong disease.
Unmet Needs in Hyperhidrosis
August 23, 2018 – 
Dee Anna Glaser, MD; Adam Friedman, MD, FAAD; and Adelaide Hebert, MD, discuss the unmet needs in treating hyperhidrosis, remarking that the disease is underreported and that more therapy options are needed. The panelists also suggest the roles in educating primary care physicians in treating patients and working with payors for insurance coverage.
Educating Clinicians and Payers About Hyperhidrosis
August 23, 2018 – 
Dee Anna Glaser, MD; Adelaide Hebert, MD; Adam Friedman, MD, FAAD; and Andy Szczotka, PharmD, provide insight on how to best educate clinicians and payers about hyperhidrosis as a medical condition. The experts also discuss the different costs involved in treating this condition.
Treating Hyperhidrosis: Glycopyrronium Tosylate
August 17, 2018 – 
Shawn Davis, PharmD, highlights the potential for treating primary axillary hyperhidrosis with glycopyrronium tosylate, an emerging treatment option.
Emerging Therapies: Glycopyrronium Tosylate
August 17, 2018 – 
Dee Anna Glaser, MD; Adelaide Hebert, MD; and Andy Szczotka, PharmD, discuss an emerging therapy, glycopyrronium tosylate, highlighting its anticipated indication, towelette formulation, and clinical study data showing its safety, efficacy, and benefit to patients.
Coverage of Current Therapies in Hyperhidrosis
August 10, 2018 – 
Shawn Davis, PharmD, reviews payer considerations for covering treatment options in hyperhidrosis.
Goals of Therapy in Treating Hyperhidrosis
August 03, 2018 – 
Dee Anna Glaser, MD; Adelaide Hebert, MD; and Adam Friedman, MD, FAAD, highlight the International Hyperhidrosis Society’s goals for educating clinicians and patients about hyperhidrosis, as well as the importance of patient-oriented treatment.
Recognizing Hyperhidrosis as a Medical Condition
July 23, 2018 – 
Shawn Davis, PharmD, remarks on the importance of recognizing hyperhidrosis as a medical condition, highlighting strategies for raising awareness within the managed care community.
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.